Late effects of oncological treatment in children;Late gevolgen van oncologische behandeling bij kinderen

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 40, 1998, Pages 2191-2195

  Heikens, J ^a,b   Somers, R ^a,b   Behrendt, H ^a,c   Oldenburger, F ^a,b   Langeveld, N E ^a,c   Bakker, P J M ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Afd Medische Oncologie ^*

^c EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; DNA TOPOISOMERASE INHIBITOR;

ALOPECIA; ARTICLE; BONE GROWTH; CANCER THERAPY; CARDIOTOXICITY; ENTERITIS; FEMALE INFERTILITY; HUMAN; HYPOPITUITARISM; IRRADIATION; LUNG DISEASE; NEPHROTOXICITY; RADIATION DOSE FRACTIONATION; RADIATION FIELD; SECOND CANCER; SOFT TISSUE; THYROID DISEASE;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RISK ASSESSMENT;

EID: 0032480554     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Lukens JN. Progress resulting from clinical trials. Solid tumors in childhood cancer. Cancer 1994.74(9 Suppl):2710-8.
2. Jaffe N. Late sequelae of cancer and cancer therapy. In: Fernbach DJ, Vietti TJ. editors Clinical pediatric oncology. St Louis: Mosby. 1991:647-72
3. Schwartz CL. Late effects of treatment in long-term survivors of cancer. Cancer Treat Rev 1995;21:355-66.
4. DeVita VT. Principles of chemotherapy. In: DeVita VT, Hellman S. Rosenberg SA, editors. Cancer principles & practice. Philadelphia. Lippincott, 1993:279-93.
5. Rubin P. The Franz Buschke lecture: late effects of chemotherapy and radiation therapy a new hypothesis. Int J Radiat Oncol Biol Phys 1984:10:5-34.
6. Sankaranarayanan K, Chakraborty R. Cancer predisposition, radio-sensitivity and the risk of radiation-induced cancers. I. Background. Radiat Res 1995:143:121-43.
7. Rothenberg M, Wilson W, Chabner BA. Complications of drug therapy for cancer: general review. In: Plowman PN, Mc Elwain T, Meadows A, editors. Complications of cancer management. Oxford: Butterworth-Heineman, 1991:3-12.
8. Fu KK. Biological basis for the interaction of chemotherapeutic agents and radiation therapy. Cancer 1985;55(9 Suppl):2123-30.
9. Shalet SM, Gibson B, Swindell R, Pearson D. Effect of spinal irradiation on growth. Arch Dis Child 1987;62:461-4.
10. Oberfield SE, Sklar C, Allen J, Walker R, McElwain M, Papadakis V, et al Thyroid and gonadal function and growth in long-term survivors of medulloblastoma/PNET. In: Green DM, D'Aglio GJ, editors. Late effects of treatment for childhood cancer. New York: Wiley-Liss, 1992:55-62.
11. Does-Van der Berg A van den, Vaan GAM de, Weerden JF van, Hahlen K, Weel-Sipman M van, Veerman AJP. Late effects among long-term survivors of childhood acute leukemia in the Netherlands: a Dutch Childhood Leukemia Study Group Report. Pediatr Res 1995;38:802-7.
12. Rappaport R, Brauner R, Czernichow P, Thibaud E, Renier D, Zucker JM. et al. Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. J Clin Endocrinol Metab 1982;54:1164-8.
13. Henderson RC, Madsen CD, Davis C, Gold SH. Bone density in survivors of childhood malignancies. J Pediatr Hematol Oncol 1996;18:367-71.
14. Felson DT, Anderson JJ. Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet 1987;i:902-6.
15. Anderson V, Smibert E, Ekert H, Godber T. Intellectual, educational, and behavioural sequelae after cranial irradiation and chemotherapy. Arch Dis Child 1994;70:476-83.
16. Mulhern RK, Hancock J, Fairclough D, Kun L. Neuropsychological status of children treated for brain tumors: a critical review and integrative analysis. Med Pediatr Oncol 1992;20:181-91.
17. Mulhern RK, Wasserman AL, Friedman AG, Fairclough D. Social competence and behavioral adjustment of children who are long-term survivors of cancer. Pediatrics 1989;83:18-25.
18. Chang P, Nesbit ME, Youngren N, Robinson LL. Personality characteristics and psychosocial adjustment of long-term survivors of childhood cancer. Psychosoc Oncol 1987;5:43-58.
19. McElwain TJ. Cardiac morbidity of chemotherapy. In: Plowman PN, Mc Elwain T, Meadows A, editors. Complications of cancer management. Oxford: Butterworth-Heineman, 1991:184-92.
20. Davis LE, Brown CEL. Peripartum heart failure in a patient treated previously with doxorubicin. Obstet Gynecol 1988;71(3 Pt 2):506-8.
21. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991;324:808-15.
22. Brosius FC, Waller BF, Roberts WC. Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. Am J Med 1981;70:519-30.
23. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993;270:1949-55.
24. O'Driscoll BR, Hasleton PS, Taylor PM, Poulter LW, Gattamaneni HR, Woodcock AA. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med 1990;323:378-82.
25. Comis RL Bleomycin pulmonary toxicity: current status and future directions. Semin Oncol 1992;19(2 Suppl 5):64-70.
26. Benoist MR, Lemerle J, Jean R, Rufin P, Scheinmann P, Paupe J. Effects of pulmonary function of whole lung irradiation for Wilm's tumour in children. Thorax 1982;37:175-80.
27. Abayomi OK, Sadeghi-Nejad A. The incidence of late endocrine dysfunction following irradiation for childhood medulloblastoma. Int J Radiat Oncol Biol Phys 1986;12:945-8.
28. Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 1993;328:87-94.
29. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991;325:599-605.
30. Heikens J, Behrendt H, Adriaanse R, Berghout A, Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease. Cancer 1996;78 2020-4.
31. Ash P. The influence of radiation on fertility in man. Br J Radiol 1980;53:271-8.
32. Stillman RJ, Schinfeld JS, Schiff I, Gelber RD, Greenberger J, Larson M. et al. Ovarian failure in long-term survivors of childhood malignancy Am J Obstet Gynecol 1981;139:62-6.
33. Green DM, Zevon MA, Lowrie G, Seigelstein N, Hall B. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. N Engl J Med 1991;325: 141-6.
34. Mulvihill JJ, Myers MH, Connelly RR, Byrne J, Austin DF, Bragg K, et al. Cancer in offspring of long-term survivors of childhood and adolescent cancer. Lancet 1987;ii:813-7.
35. Dewit L, Anninga JK, Hoefnagel CA, Nooijen WJ. Radiation injury in the human kidney: a prospective analysis using specific scintigraphic and biochemical endpoints. Int J Radiat Oncol Biol Phys 1990,19:977-83.
36. Cassady JR. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys 1995;31:1249-56.
37. Fjeldborg P, Sorensen J, Helkjaer PE. The long-term effect of cisplatin on renal function. Cancer 1986;58:2214-7.
38. Burk CD, Restaino I, Kaplan BS, Meadows AT. Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor. J Pediatr 1990;117(2 Pt 1):331-5.
39. Stewart FA. Mechanism of bladder damage and repair after treatment with radiation and cytostatic drugs. Br J Cancer Suppl 1986; 7:280-91.
40. Smalley SR, Evans RG. Radiation morbidity to the gastrointestinal tract and liver. In: Plowman PN, Mc Elwain T, Meadows A, editors. Complications of cancer management. Oxford: Butterworth-Heineman, 1991:272-308.
41. Johnson PM, Grossman FM, Atkins HL. Radiation induced hepatic injury; its detection by scintillation scanning. Am J Roentgenol Radium Ther Nucl Med 1967;99:453-62.
42. Liesner RJ, Leiper AD, Hann IM, Chessells JM. Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood. J Clin Oncol 1994;12:916-24.
43. Barrett A, Nicholls J, Gibson B Late effects of total body irradiation. Radiother Oncol 1987;9:131-5.
44. Neglia JP, Meadows AT, Robison LL, Kim TH, Newton WA, Ruymann FR, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991;325:1330-6.
45. Olsen JH, Garwicz S, Hertz H, Jonmundsson G, Langmark F, Lanning M, et al. Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. BMJ 1993;307:1030-6.
46. Pui CH, Ribeiro RC, Hancock ML, Rivera GK, Ewans WE, Raimondi SC, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991;325:1682-7.
47. Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 1987; 56:339-47.
48. Bhatia S, Robinson LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F. et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996;334:745-51.
49. Malkin D, Li FP, Strong LC. Fraumeni jr JF, Nelson CE, Kim DH, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990,250:1233-8.